Natural Biocon (India) Limited (BOM:543207)
India · Delayed Price · Currency is INR 3.810
+0.110 (2.97%)
At close: Aug 14, 2026
Natural Biocon (India) Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 0.4 | 0.45 | 1.88 | 4.01 | 2.09 |
Cash & Short-Term Investments | 0.4 | 0.4 | 0.45 | 1.88 | 4.01 | 2.09 |
Cash Growth | -12.17% | -12.14% | -75.97% | -53.12% | 91.63% | 462.06% |
Accounts Receivable | - | 51.43 | 56.63 | 48.73 | 6.28 | 4.92 |
Receivables | - | 51.43 | 56.63 | 48.73 | 6.28 | 4.92 |
Inventory | - | - | 1.66 | 1.61 | 9.16 | 0.55 |
Prepaid Expenses | - | - | - | - | 0.32 | - |
Other Current Assets | - | 0.52 | 11.66 | 11.66 | 1.74 | 1.74 |
Total Current Assets | - | 52.35 | 70.41 | 63.89 | 21.51 | 9.31 |
Property, Plant & Equipment | - | 33.04 | 32.9 | 32.97 | 32.97 | 32.97 |
Long-Term Investments | - | 211.24 | 211.24 | - | - | - |
Other Long-Term Assets | - | 0.06 | 0.06 | 0.06 | 80.69 | 80.7 |
Total Assets | - | 368.39 | 385.22 | 167.65 | 135.17 | 122.97 |
Accounts Payable | - | 47.16 | 54.68 | 40.92 | 10.16 | 0.23 |
Accrued Expenses | - | - | - | - | 0.17 | 0.23 |
Short-Term Debt | - | 3.76 | 2.84 | 0.66 | 1.54 | - |
Current Portion of Long-Term Debt | - | - | - | - | - | 1.63 |
Current Income Taxes Payable | - | - | - | 1.95 | 0.79 | 0.28 |
Other Current Liabilities | - | 10.15 | 9.01 | 0.29 | 0.21 | - |
Total Current Liabilities | - | 61.06 | 66.52 | 43.82 | 12.87 | 2.36 |
Other Long-Term Liabilities | - | - | - | - | 0 | 0.1 |
Total Liabilities | - | 61.06 | 66.52 | 43.82 | 12.87 | 2.46 |
Common Stock | - | 257.83 | 257.83 | 113.73 | 113.73 | 113.73 |
Additional Paid-In Capital | - | - | 50.44 | - | - | - |
Retained Earnings | - | - | 10.44 | 10.1 | 8.58 | 6.78 |
Comprehensive Income & Other | - | 49.49 | - | - | - | - |
Shareholders' Equity | 307.32 | 307.32 | 318.7 | 123.83 | 122.3 | 120.51 |
Total Liabilities & Equity | - | 368.39 | 385.22 | 167.65 | 135.17 | 122.97 |
Total Debt | 3.76 | 3.76 | 2.84 | 0.66 | 1.54 | 1.63 |
Net Cash (Debt) | -3.36 | -3.36 | -2.38 | 1.22 | 2.47 | 0.46 |
Net Cash Growth | - | - | - | -50.50% | 433.00% | - |
Net Cash Per Share | - | -0.17 | -0.11 | 0.11 | 0.22 | 0.04 |
Filing Date Shares Outstanding | - | 23.35 | 25.78 | 11.37 | 11.37 | 11.37 |
Total Common Shares Outstanding | - | 23.35 | 25.78 | 11.37 | 11.37 | 11.37 |
Working Capital | - | -8.72 | 3.89 | 20.07 | 8.64 | 6.95 |
Book Value Per Share | 13.16 | 13.16 | 12.36 | 10.89 | 10.75 | 10.60 |
Tangible Book Value | 307.32 | 307.32 | 318.7 | 123.83 | 122.3 | 120.51 |
Tangible Book Value Per Share | 13.16 | 13.16 | 12.36 | 10.89 | 10.75 | 10.60 |
Machinery | - | - | 0.07 | 0.07 | 0.07 | - |
Construction In Progress | - | - | 32.9 | 32.9 | 32.9 | - |